Citadel Advisors - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is and the CUSIP is 14888U951. A total of 2 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$13,000
+62.5%
5,300
+96.3%
0.00%
Q3 2015$8,000
-33.3%
2,700
-10.0%
0.00%
Q2 2015$12,000
-33.3%
3,000
-28.6%
0.00%
Q1 2015$18,000
+500.0%
4,200
+281.8%
0.00%
Q4 2014$3,000
-96.9%
1,100
-96.3%
0.00%
Q3 2014$98,000
+2350.0%
29,500
+2007.1%
0.00%
Q2 2014$4,000
+300.0%
1,400
+366.7%
0.00%
Q4 2013$1,0003000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 1,900$6,0000.00%
SIMPLEX TRADING, LLC 166$55,0000.00%
View complete list of CATALYST PHARMACEUTICALS INC shareholders